Dock Street Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-6,715
| Closed | -$3.97M | – | 63 |
|
2022
Q2 | $3.97M | Sell |
6,715
-53
| -0.8% | -$31.3K | 0.87% | 25 |
|
2022
Q1 | $4.73M | Sell |
6,768
-76
| -1% | -$53.1K | 0.85% | 26 |
|
2021
Q4 | $4.32M | Buy |
6,844
+119
| +2% | +$75.1K | 0.71% | 29 |
|
2021
Q3 | $4.07M | Buy |
6,725
+41
| +0.6% | +$24.8K | 0.76% | 31 |
|
2021
Q2 | $3.73M | Sell |
6,684
-1,055
| -14% | -$589K | 0.7% | 30 |
|
2021
Q1 | $3.66M | Buy |
7,739
+154
| +2% | +$72.9K | 0.76% | 29 |
|
2020
Q4 | $3.66M | Buy |
+7,585
| New | +$3.66M | 0.76% | 29 |
|